Evidence map›Paper›PMID 41798170›Full record

SynthesisFrontiers in nutrition2025

The role of bovine colostrum in feeding intolerance in preterm neonates: a systematic review and meta-analysis of randomized controlled trials.

Jia Yao, Bo Zheng, Jie Zhang, Fen Xu, Jianbo Zhuang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Effects ofSexual medicine · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jia YaoNICU, Suzhou Ninth People's Hospital, Suzhou, China.
Bo ZhengGlobal Visiting Department, UNC of Greensboro, Greensboro, NC, United States.
Jie ZhangNICU, Suzhou Ninth People's Hospital, Suzhou, China.
Fen XuNICU, Suzhou Ninth People's Hospital, Suzhou, China.
Jianbo ZhuangNICU, Suzhou Ninth People's Hospital, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Feeding intolerance is common in preterm infants and may lead to poor weight gain and prolonged hospitalization. Bovine colostrum, owing to its rich content of bioactive components such as immunoglobulins, lactoferrin, and growth factors, has been suggested to reduce feeding intolerance and promote gut maturation in preterm infants; however, available clinical trials provide inconsistent evidence regarding its efficacy. Therefore, this study aimed to conduct a systematic review and meta-analysis to evaluate the effects of bovine colostrum supplementation on feeding intolerance, necrotizing enterocolitis, and time to full enteral feeding in preterm infants. Method: We searched five databases for randomized controlled trials (RCTs) on bovine colostrum (BC) use in preterm neonates from their inception to 8 July 2025. Outcomes included feeding intolerance, necrotizing enterocolitis (NEC), and time to full enteral feeding to 120 mL/kg/d (TFF120). Data were analyzed using RevMan 5.3. Result: A total of four RCTs (670 infants) were included in this study. BC supplementation was associated with a lower incidence of feeding intolerance (RR = 0.76; 95% CI: 0.61-0.94) with low heterogeneity ( Conclusion: BC cannot be recommended for preterm infants based on current evidence. The observed reduction in feeding intolerance is likely due to performance bias, with no proven benefit for NEC or TFF120. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251102646, identifier CRD420251102646.

Indexed as

bovine colostrumfeeding intolerancemeta-analysisNECpreterm neonatesystematic reviewTFF120

Identifiers

PMID41798170
PMCPMC12962896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.